CD274 and interstitial lung disease: Anti–PD-1/PD-L1 antibody monotherapy causes a wide range of irAEs, including ILD (35%), hepatitis (22%), colitis (17%), neurological events (15%), and myocarditis (8%), which are often fatal when the vital organs are involved [1].